Antipodes Partners »

Alnylam Pharmaceuticals shares owned by Antipodes Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Antipodes Partners from 13F filings

Historical chart of Antipodes Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Antipodes Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Antipodes Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $36M 189k 191.41
2023-09-30 $20M 112k 174.03
2023-06-30 $10k 56 178.57
2023-03-31 $28k 140 200.00
2022-12-31 $28k 118 237.29